Skip to main content
. Author manuscript; available in PMC: 2011 May 5.
Published in final edited form as: World J Surg. 2009 Nov;33(11):2452–2457. doi: 10.1007/s00268-009-0175-3

Fig. 3.

Fig. 3

Inhibition of the PI3K-Akt pathway reduces ASCL1 and CgA. Western blot analysis showed a decrease in levels of ASCL1, a proneuroendocrine transcription factor, and chromogranin A (CgA), a marker of hormonal secretion. Inhibition of the PI3K-Akt pathway leads to a decrease in the NE phenotypte and hormonal secretion